Summary Our findings from a previous study, that increased consumption of beta-carotene and vitamin C is associated with favourable prognostic indices in patients with breast cancer, have been borne out by our current study of patient survival over a 6-year period. The results of the current study point to beta-carotene consumption as the dietary variable most significantly associated with improved survival. Only one death occurred in the group with the highest consumption of beta-carotene, while there were eight and 12 deaths in the intermediate and lowest groups of consumption respectively. The possible antiproliferative effects of beta-carotene have been recognised for some time, with investigations being focused more recently on its derivative, retinoic acid, which has been found to improve differentiation in many tissues, including cell lines derived from mammary carcinomas. Retinoids have been associated with significant clinical responses in a variety of tumours, and chemoprevention trials using beta-carotene have been undertaken for many malignancies. However, beta-carotene has not yet been used in clinical trials to evaluate its potential for the treatment of breast cancer. A large-scale clinical trial is necessary to determine the effectiveness of beta-carotene in reducing the chances of recurrence of breast cancer, and in preventing the development of new cancers.
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There is considerable variation in the growth rate of breast cancer: in some patients there is rapid progression to death, while others remain in remission for many years before relapsing or continue remission indefinitely. There has been a vast increase in our knowledge of many of the factors which are indicators of this progression or otherwise, such as growth factors, oncogenes and anti-oncogenes. What is still poorly understood is the role played by the host environment. There is some evidence that diet may be an important factor, and this study explores this concept further. If nutritional factors can be identified, there is considerable potential for using this information for chemoprevention of breast cancer or as a modifier of tumour growth in patients with established cancer.
We previously undertook a study which demonstrated that an increase in the consumption of sugar, fibre, fruit and vegetables and some vitamins -in particular beta-carotene and vitamin C -is associated with favourable breast cancer growth characteristics (Ingram et al., 1992) . Of note were improvement in the degree of differentiation of the tumours and an increase in the levels of oestrogen and progesterone receptors with increasing consumption of these nutrients. The patients were treated by their surgeons along conventional lines with either mastectomy or lumpectomy and radiotherapy. Most One hundred and three women were included in the study. This includes the 91 women in the preceding study (Ingram et al., 1992) identified from the records at the Queen Elizabeth II Medical Centre, Perth, Western Australia, in 1985 and 1986 . Three months after operation for their primary lesion, the women were interviewed at home using a structured questionnaire, and each woman completed a food frequency questionnaire in regard to her dietary habits up until the time of her breast cancer diagnosis.
Nutritional consumption After verbal instruction and demonstration of standard portion sizes, each woman completed the questionnaire in her own time and returned the completed questionnaire by post. Returned questionnaires were checked for completeness and any problems resolved by telephone. The food frequency questionnaire identified 179 different foods and was scored for portion size and frequency of consumption. Despite this, in two subjects the dietary data were incomplete and so these were excluded from the dietary analysis. Nutrient intakes were calculated by the program FREQUAN, developed by the Commonwealth Scientific and Industrial Research Organisation Division of Human Nutrition (Baghurst & Record, 1984) . This is based on the food tables of McCance and Widdowson, although for sources of fat, Australian values were substituted where data were available.
Mortality data
Access was gained to the computerised mortality data compiled by the Australian Bureau of Statistics. Each of the 103 women included in this study was searched on this database, which provides information on the date and certified cause of all deaths in Western Australia. In cases where the patient had died, the date of her death and whether it was related to her breast cancer was recorded.
Statistical analysis
The data were entered into a personal computer and analysed using the program EPILOG (Epicenter Software, Pasadena, CA, USA). The probability of survival was calculated by Kaplan-Meier estimate, using a log-rank statistic.
Results

Mortality
Of the 103 subjects, 27 had died. Of these, 21 had died with advanced breast cancer and six from other causes. These cases were censored in the analyses. The median duration of follow-up was 81 months (range 71-98 months).
Nutritional associations (Tables I and II) The most important findings from the nutrient consumption assessment were associated with vitamin consumption, in particular beta-carotene and vitamin C. At high levels of consumption, there were significantly fewer deaths from breast cancer: only one in the group of highest beta-carotene consumers compared with eight in the intermediate group and 12 in the lowest group (trend P = 0.0012) (Figure 1 ). The equivalent figures for vitamin C were 3, 7 and 11 deaths for the highest, intermediate and lowest consumption groups respectively (trend P = 0.0286). Not surprisingly, these figures are reflected to the level of fruit consumption in the food group analyses. There were 12 deaths in the lowest total fruit consumption group, compared with five in the intermediate group and three in the highest (trend P = 0.0107) (Figure 2 ). This benefit applied to both orange/yellow fruit (oranges, melon, stonefruits) as well as other fruits (apple, banana, berries, grapes, dried fruits). No other nutrient or food group reached significance, although there appeared to be a higher mortality at high levels of consumption of eggs and red meats in the food group analyses.
Discussion
The observation that the type of diet consumed influences survival from breast cancer is not surprising. Several previous studies have demonstrated associations between diet and prognostic factors (Verreault et al., 1988; Holm et al., 1989; Ingram et al., 1992) . Verreault et al. found that a high saturated fat intake was associated with increased node involvement, with the converse being true for polyunsaturated fat. Holm et al. found that low fibre intake was associated with larger tumours and oestrogen receptor negativity with low carbohydrate and retinol intake. In our study (Ingram et al., 1992) we demonstrated a strong association for beta-carotene consumption and for vitamin C consumption, and a degree of improvement in differentiation with increasing consumption of these nutrients. The current finding of improved survival with a high consumption of beta-carotene and of vitamin C is therefore not unexpected, given the fact that tumour differentiation is one of the best predictors of prognosis. It is nevertheless reassuring to find that our initial observation is confirmed with survival. What is unknown is whether this population continued with their original diet, or subsequently changed, as they were not reassessed after the initial interview. Is the diet at time of surgery important, or is it necessary that these patients continue their diet in the post-surgery years to gain benefit? (Tables I and II) , beta-carotei most significant association with si breast cancer deaths in the group consumption, eight in the intermedia group with the highest consumption carotene is one of a large group particularly important because it is t carotenoid, being converted in the gu turn is degraded to retinoic acid. R differentiation and growth of many Sporn & Roberts, 1983 (Hunter, 1993 High objective response rates have been produced with combined 1 3-cis-retinoic acid and alpha-interferon in patients with squamous cell carcinoma of the skin (Lippman et al., rves for breast cancer 1992a) and of the cervix (Lippman et al., 1992b (Lotan, 1980; tion 
